FibroGen to Report Second Quarter 2025 Financial Results

FibroGen to Report Second Quarter 2025 Financial Results GlobeNewswire August 04, 2025 SAN FRANCISCO, Aug. 04, 2025 (GLOBE NEWSWIRE) — FibroGen, Inc. (NASDAQ: FGEN) will announce second quarter 2025 financial results on Monday, August 11 after the markets close. FibroGen will also conduct a conference call on that day at 5:00 PM Eastern Time with […]

Diamondback Energy, Inc. Announces Second Quarter 2025 Financial and Operating Results

Diamondback Energy, Inc. Announces Second Quarter 2025 Financial and Operating Results GlobeNewswire August 04, 2025 MIDLAND, Texas, Aug. 04, 2025 (GLOBE NEWSWIRE) — Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback” or the “Company”) today announced financial and operating results for the second quarter ended June 30, 2025. SECOND QUARTER 2025 AND RECENT HIGHLIGHTS Average oil production

Currenc Group Inc. Announces Second Quarter and First Half 2025 Financial Results

Currenc Group Inc. Announces Second Quarter and First Half 2025 Financial Results GlobeNewswire August 04, 2025 SINGAPORE, Aug. 04, 2025 (GLOBE NEWSWIRE) — Currenc Group Inc. (Nasdaq: CURR) (“Currenc” or the “Company”), a fintech pioneer empowering financial institutions worldwide with artificial intelligence (AI) solutions, today announced its financial results for the second quarter and six

Viper Energy, Inc., a Subsidiary of Diamondback Energy, Inc., Reports Second Quarter 2025 Financial and Operating Results

Viper Energy, Inc., a Subsidiary of Diamondback Energy, Inc., Reports Second Quarter 2025 Financial and Operating Results GlobeNewswire August 04, 2025 MIDLAND, Texas, Aug. 04, 2025 (GLOBE NEWSWIRE) — Viper Energy, Inc., (NASDAQ:VNOM) (“Viper” or the “Company”), a subsidiary of Diamondback Energy, Inc. (NASDAQ:FANG) (“Diamondback”), today announced financial and operating results for the second quarter

Semler Scientific® Reports Second Quarter 2025 Financial Results, BTC Holdings of 5,021 and BTC Yield of 31.3% YTD through July 31, 2025

Semler Scientific, Inc. (Nasdaq: SMLR), a publicly traded company that has adopted Bitcoin as its primary treasury reserve asset and is one of the leading corporate holders of Bitcoin, today reported financial results for the second quarter ended June 30, 2025 and provided an update on its Bitcoin holdings and other key performance indicators (KPIs).

VolitionRx Announces Pricing of $1.2 Million Registered Direct Offering

VolitionRx Limited (NYSE American: VNRX) (“Volition” or the “Company”), a multi-national epigenetics company, announced today that it has entered into definitive agreements for the purchase and sale of (i) 156,250 shares of its common stock to certain directors and executive officers of the Company (collectively, the “Insiders”) at an offering price of $0.64 per share,

Axon reports Q2 2025 revenue of $669 million, up 33% year over year

https://mma.prnewswire.com/media/231466/axon_logo.jpg — Software & Services revenue grows 39% to $292 million — Annual recurring revenue grows 39% to $1.2 billion — Net income of $36 million supports non-GAAP net income of $174 million and Adjusted EBITDA of $172 million — Raises full year revenue outlook to a range of $2.65 billion to $2.73 billion, up

Heidrick & Struggles Delivers 14% Revenue Growth in Q2, Driving Strong Profitability

Q2 Revenue Exceeds High End of Outlook All Business Segments Contribute to Consolidated Revenue Growth Second Quarter 2025 Financial Highlights: — Net revenue of $317.2 million increased 13.9% year over year — Adjusted EBITDA was $33.9 million with adjusted EBITDA margin of 10.7% — Adjusted net income was $18.1 million with adjusted diluted earnings per

Ardelyx Reports Second Quarter 2025 Financial Results and Provides Business Update

Ardelyx Reports Second Quarter 2025 Financial Results and Provides Business Update GlobeNewswire August 04, 2025 Company reports strong commercial performance in the second quarter, recording $97.7 million in total revenue, reflecting 33% growth year-over-year IBSRELA generated net sales revenue of $65.0 million; XPHOZAH generated net sales revenue of $25.0 million Company ends Q2 with $238.5

ALLEGIANT TRAVEL COMPANY SECOND QUARTER 2025 FINANCIAL RESULTS

Second quarter2025 GAAP diluted loss per share of$(3.62) Second quarter2025 adjusted airline-only diluted earnings per share of $1.86(1)(2) Second quarter2025 adjusted diluted earnings per share of $1.23(1)(2) Allegiant Travel Company (NASDAQ: ALGT) today reported the below financial results for second quarter 2025, as well as comparisons to the prior year. https://mma.prnewswire.com/media/486546/AllegiantLogoBlue__NoTagline_2014_Logo.jpg “During the quarter, we

Scroll to Top